China 
Africa 
Explore chapters and articles related to this topic
Complications of Equine Anesthesia
Published in Michele Barletta, Jane Quandt, Rachel Reed, Equine Anesthesia and Pain Management, 2023
Treatment of atrial fibrillation includes: Lidocaine: 2 mg/kg IV bolus, 50 µg/kg/min CRI.Quinidine: 1 mg/kg slow IV (over 10 minutes) repeated up to a total of 4 mg/kg.Electrocardioconversion; more likely to be successful if patient has not been in atrial fibrillation for a long period of time.
Nutraceuticals and Brain Disorders
Published in Debarshi Kar Mahapatra, Cristóbal Noé Aguilar, A. K. Haghi, Applied Pharmaceutical Practice and Nutraceuticals, 2021
Akshada Atul Bakliwal, Vijay Sharadkumar Chudiwal, Swati Gokul Talele
Baicalein is a flavonoid extracted from the base of Scutellaria baicalensis, at traditional Chinese herb usually known as Huang Qin. Baicalein has been demonstrated to be a powerful cancer prevention agent in rodent essential neurons. Another investigation in rodents likewise demonstrated enemy of inflammatory properties of baicalein in exploratory horrible cerebrum injury. Baicalein was seen as neuroprotective in a few test models of PD, including MPTP-actuated neurotoxicity and 6-OHDA-instigated neurotoxicity. It has additionally been appeared to hinder fibrillation and disaggregate the existing fibrils in the brain.
Arrhythmias in Pregnancy
Published in Afshan B. Hameed, Diana S. Wolfe, Cardio-Obstetrics, 2020
Dana Senderoff Berger, Lee Brian Padove
There is an increasing incidence of atrial fibrillation in pregnancy, with recent literature citing it as being the leading cause of hospital admissions among sustained arrhythmias in pregnancy [21]. Risk factors include older age, obstructive sleep apnea, underlying congenital heart disease, and hypertension [21]. Pregnancy-associated atrial fibrillation is also known as lone atrial fibrillation, that is, without a prior history of atrial fibrillation outside of pregnancy and no structural heart disease. These episodes of atrial fibrillation are usually self-limited with low risk of embolic events. There appears to be a high variability in the interventions and care in this group [22]. The general basis of treatment of atrial fibrillation is heart rate/rhythm control, and prevention of stroke.
Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study
Published in Postgraduate Medicine, 2023
Sahith Reddy Thotamgari, Aakash R. Sheth, Harsh P. Patel, Harigopal Sandhyavenu, Bhavin Patel, Udhayvir S. Grewal, Mohammad Alfrad Nobel Bhuiyan, Sourbha S. Dani, Paari Dominic
Cancer is an independent risk factor for atrial fibrillation [3,8,18]. Patients with cancer and AF have higher odds of developing life-threatening complications such as systemic thromboembolism and heart failure than normal population [19]. Hence, AF is an important comorbidity that needs to be addressed adequately in the high-risk population of patients with cancer. Catheter ablation is among the first line treatment options for atrial fibrillation owing to its success in reducing recurrences of atrial fibrillation [20]. However, due to lack of appropriate representation of patients with cancer in major RCTs involving catheter ablation including the recent CABANA [21] or CASTLE AF [22] trials, ablation therapy in these patients is not well defined [23–25]. In this study, we try to shed light on this important topic.
Factors associated with medication persistence among ischemic stroke patients: a systematic review
Published in Neurological Research, 2020
Dong Eun Jang, Julie Ann Zuñiga
Disease comorbidity/history affects medication persistence differently, depending on disease type. Stroke patients with a history of hypertension and dyslipidemia but without atrial fibrillation and anxiety disorder showed better medication persistence. In the two prior systematic reviews [23,24], better knowledge of medications, including an understanding of medications’ rationales, ways to refill prescriptions, and previous treatments with the same medication class, positively affected medication adherence, so self-care could play a positive role in stroke care. However, added disease burden from atrial fibrillation and negative emotions from anxiety disorders negatively affected medication persistence. Stroke patients with atrial fibrillation require continuous blood monitoring and diet control to prevent bleeding [52]. Also, negative emotions such as anxiety or concerns about medication have predicted reduced adherence [23]. Other disease-related factors associated with medication persistence were length of hospital stay, TIA patients rather than ischemic stroke patients, and symptom severity. Health care providers should use patient-centered secondary preventative strategies for patients with multiple morbidities, tailored for stroke type.
Thermal ablation of biological tissues in disease treatment: A review of computational models and future directions
Published in Electromagnetic Biology and Medicine, 2020
Sundeep Singh, Roderick Melnik
Thermal ablative therapies have demonstrated rapid progress over the past decade in providing a viable and safe alternative to surgery. Among different hyperthermic ablative modalities that utilize electromagnetic heating, RFA is a well-established and extensively studied modality for treating: (a) different types of cancer (e.g. liver, kidney, bone, lung, breast, prostate and adrenal), (b) cardiac arrhythmia and some types of atrial fibrillation, and (c) chronic nerve pain by providing rapid pain relief. While MWA and nanoparticles mediated laser therapy being rapidly progressing modalities mainly focused on treating tumours. Additionally, the application of laser therapy has also been explored in neurosurgery for treating different types of pathological disorders in brain. Computational modelling has become an important tool that not only assists in providing a priori estimates of the treatment outcomes with better visualizations but can also be used for educational purposes, e.g. providing training and online support to the physicians.